Arvee Laboratories (India) Ltd.(IN:ARVEE)
₹197.05-5.95 (-2.93%)
IN:ARVEE
Arvee Laboratories (India) Ltd. financials statements
₹197.05
At close:-5.95 (-2.93%)
Want to see IN:ARVEE full AI Analyst Report?
Arvee Laboratories (India) Ltd. (ARVEE) Ratios
0 Followers
Arvee Laboratories (India) Ltd. Ratios
IN:ARVEE's free cash flow for Q2 2027 was ₹0.00. For the 2027 fiscal year, IN:ARVEE's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 3.35 | 4.75 | 2.42 | 2.44 | 1.40 |
| Quick Ratio | 2.13 | 3.76 | 1.50 | 1.92 | 0.99 |
| Cash Ratio | 0.44 | 0.05 | 0.27 | 0.06 | 0.36 |
| Solvency Ratio | 0.39 | 0.48 | 0.28 | 0.58 | 0.26 |
| Operating Cash Flow Ratio | -0.01 | 0.03 | 0.53 | 0.33 | 0.09 |
| Short-Term Operating Cash Flow Coverage | 0.00 | 0.00 | 0.00 | 0.00 | 0.22 |
| Net Current Asset Value | ₹ 157.02M | ₹ 149.00M | ₹ 77.07M | ₹ 109.47M | ₹ 59.46M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.22 |
| Debt-to-Equity Ratio | 0.03 | 0.03 | 0.03 | 0.04 | 0.41 |
| Debt-to-Capital Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 |
| Financial Leverage Ratio | 1.28 | 1.22 | 1.31 | 1.38 | 1.91 |
| Debt Service Coverage Ratio | 14.03 | 14.25 | 11.23 | 16.98 | 0.61 |
| Interest Coverage Ratio | 8.45 | 9.90 | 6.20 | 14.57 | 6.35 |
| Debt to Market Cap | 0.01 | 0.01 | 0.01 | 0.01 | 0.19 |
| Interest Debt Per Share | 1.22 | 1.16 | 1.13 | 1.26 | 8.58 |
| Net Debt to EBITDA | -0.68 | 0.19 | -0.24 | 0.05 | 0.37 |
| Profitability Margins | |||||
| Gross Profit Margin | 35.44% | 31.60% | 13.67% | 28.25% | 30.33% |
| EBIT Margin | 6.30% | 8.11% | 6.85% | 10.69% | 7.77% |
| EBITDA Margin | 10.15% | 11.09% | 11.79% | 14.09% | 13.00% |
| Operating Profit Margin | 6.30% | 6.40% | 5.10% | 9.22% | 7.77% |
| Pretax Profit Margin | 7.71% | 7.46% | 6.03% | 10.06% | 7.72% |
| Net Profit Margin | 8.02% | 5.58% | 3.47% | 6.72% | 5.68% |
| Continuous Operations Profit Margin | 8.02% | 5.58% | 3.47% | 6.72% | 5.68% |
| Net Income Per EBT | 103.95% | 74.80% | 57.49% | 66.81% | 73.52% |
| EBT Per EBIT | 122.49% | 116.59% | 118.29% | 109.08% | 99.43% |
| Return on Assets (ROA) | 5.84% | 5.63% | 2.75% | 10.65% | 6.52% |
| Return on Equity (ROE) | 7.48% | 6.87% | 3.61% | 14.68% | 12.49% |
| Return on Capital Employed (ROCE) | 5.56% | 7.34% | 4.95% | 18.94% | 16.10% |
| Return on Invested Capital (ROIC) | 5.56% | 5.49% | 2.83% | 12.65% | 8.79% |
| Return on Tangible Assets | 5.84% | 5.63% | 2.75% | 10.65% | 6.53% |
| Earnings Yield | 1.71% | 1.33% | 0.68% | 4.25% | 5.85% |
| Efficiency Ratios | |||||
| Receivables Turnover | 3.02 | 4.58 | 4.96 | 4.91 | 5.57 |
| Payables Turnover | 3.20 | 8.04 | 3.95 | 5.55 | 3.44 |
| Inventory Turnover | 2.21 | 5.78 | 4.10 | 9.62 | 4.42 |
| Fixed Asset Turnover | 1.79 | 2.41 | 1.98 | 4.32 | 3.20 |
| Asset Turnover | 0.73 | 1.01 | 0.79 | 1.58 | 1.15 |
| Working Capital Turnover Ratio | 1.81 | 2.85 | 2.69 | 5.67 | 7.37 |
| Cash Conversion Cycle | 171.86 | 97.41 | 70.36 | 46.58 | 42.10 |
| Days of Sales Outstanding | 121.05 | 79.64 | 73.53 | 74.36 | 65.58 |
| Days of Inventory Outstanding | 164.89 | 63.15 | 89.12 | 37.93 | 82.58 |
| Days of Payables Outstanding | 114.08 | 45.38 | 92.29 | 65.71 | 106.07 |
| Operating Cycle | 285.94 | 142.79 | 162.65 | 112.29 | 148.17 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -0.06 | 0.11 | 3.31 | 2.66 | 1.55 |
| Free Cash Flow Per Share | -2.63 | -1.57 | 0.97 | 1.31 | -0.53 |
| Dividend Paid and CapEx Coverage Ratio | -0.02 | 0.06 | 1.42 | 1.97 | 0.75 |
| Capital Expenditure Coverage Ratio | -0.02 | 0.06 | 1.42 | 1.97 | 0.75 |
| Operating Cash Flow Coverage Ratio | -0.06 | 0.12 | 3.66 | 2.93 | 0.19 |
| Operating Cash Flow to Sales Ratio | -0.00 | 0.00 | 0.12 | 0.05 | 0.04 |
| Free Cash Flow Yield | -1.97% | -1.07% | 0.69% | 1.49% | -1.27% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 58.45 | 75.05 | 147.74 | 23.54 | 17.08 |
| Price-to-Sales (P/S) Ratio | 4.69 | 4.20 | 5.12 | 1.58 | 0.97 |
| Price-to-Book (P/B) Ratio | 4.37 | 5.18 | 5.34 | 3.46 | 2.13 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -50.88 | -93.28 | 144.19 | 67.12 | -78.85 |
| Price-to-Operating Cash Flow Ratio | -2127.88 | 1360.99 | 42.42 | 33.11 | 26.74 |
| Price-to-Earnings Growth (PEG) Ratio | 3.35 | 0.71 | -1.98 | 0.39 | 0.84 |
| Enterprise Value Multiple | 45.50 | 38.10 | 43.19 | 11.28 | 7.83 |
| Enterprise Value | 1.46B | 1.63B | 1.55B | 974.39M | 480.07M |
| EV to EBITDA | 45.50 | 38.10 | 43.19 | 11.28 | 7.83 |
| EV to Sales | 4.62 | 4.23 | 5.09 | 1.59 | 1.02 |
| EV to Free Cash Flow | -50.14 | -93.76 | 143.40 | 67.44 | -82.77 |
| EV to Operating Cash Flow | -2096.62 | 1367.90 | 42.18 | 33.27 | 28.06 |
| Tangible Book Value Per Share | 30.57 | 28.27 | 26.29 | 25.46 | 19.43 |
| Shareholders’ Equity Per Share | 30.63 | 28.27 | 26.30 | 25.46 | 19.45 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.04 | 0.25 | 0.43 | 0.33 | 0.26 |
| Revenue Per Share | 28.57 | 34.81 | 27.40 | 55.60 | 42.78 |
| Net Income Per Share | 2.29 | 1.94 | 0.95 | 3.74 | 2.43 |
| Tax Burden | 1.04 | 0.75 | 0.57 | 0.67 | 0.74 |
| Interest Burden | 1.22 | 0.92 | 0.88 | 0.94 | 0.99 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.29 | 0.18 | 0.20 | 0.02 | 0.06 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.03 | 0.06 | 3.48 | 0.48 | 0.47 |
Currency in INR

